Patents by Inventor Gerard D. Schellenberg

Gerard D. Schellenberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040006779
    Abstract: The present invention discloses nucleic acid molecules encoding WRN gene products, expression vectors and host cells suitable for expressing such products.
    Type: Application
    Filed: February 25, 2003
    Publication date: January 8, 2004
    Inventors: Ying-Hui Fu, Chang-En Yu, Junko Oshima, John T. Mulligan, Gerard D. Schellenberg
  • Publication number: 20030180880
    Abstract: The present invention discloses nucleic acid molecules encoding AD4 gene products, expression vectors and host cells suitable for expressing such gene products. Also disclosed are methods for treating, preventing, and diagnosing Alzheimer's Disease.
    Type: Application
    Filed: June 24, 2002
    Publication date: September 25, 2003
    Applicant: University of Washington
    Inventors: Rudolph E. Tanzi, Gerard D. Schellenberg, Wilma Wasco, Ephrat Levy-Lahad, Thomas D. Bird, David J. Galas
  • Patent number: 6583112
    Abstract: The present invention discloses nucleic acid molecules encoding WRN gene products, expression vectors and host cells suitable for expressing such products.
    Type: Grant
    Filed: July 17, 2000
    Date of Patent: June 24, 2003
    Inventors: Ying-Hui Fu, Chang-En Yu, Junko Oshima, John T. Mulligan, Gerard D. Schellenberg
  • Patent number: 6468791
    Abstract: The present invention discloses nucleic acid molecules encoding AD4 gene products, expression vectors and host cells suitable for expressing such gene products. Also disclosed are methods for treating, preventing, and diagnosing Alzheimer's Disease.
    Type: Grant
    Filed: August 16, 1999
    Date of Patent: October 22, 2002
    Assignees: The General Hospital Corp., University of Washington
    Inventors: Rudolph E. Tanzi, Gerard D. Schellenberg, Wilma Wasco, Ephrat Levy-Lahad, Thomas D. Bird, David J. Galas
  • Patent number: 6090620
    Abstract: The present invention discloses nucleic acid molecules encoding WRN gene products, expresion vectors, viral vectors, and host cells suitable for expressing such products.
    Type: Grant
    Filed: December 27, 1996
    Date of Patent: July 18, 2000
    Assignee: University of Washington
    Inventors: Ying-Hui Fu, Chang-En Yu, Junko Oshima, John T. Mulligan, Gerard D. Schellenberg
  • Patent number: 5449604
    Abstract: Method for isolating a DNA segment indicative of an Alzheimer's disease trait in a family population, wherein said family population consists essentially of a plurality of blood relatives of an individual having a chromosome 14 Alzheimer's disease trait, by: preparing a test sample of immobilized separated genomic DNA fragments from a plurality of the blood relatives, contacting each of the test samples with a test oligonucleotide under conditions permitting hybridization of complementary single stranded DNA molecules, wherein the test oligonucleotide is complementary with at least a portion of a genetic marker located between band q11.2 and band q32.
    Type: Grant
    Filed: October 21, 1992
    Date of Patent: September 12, 1995
    Assignee: University of Washington
    Inventors: Gerard D. Schellenberg, Thomas D. Bird, Ellen M. Wijsman